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Abstract
Congenital diseases requiring reconstruction of parts of the gastrointestinal tract,
skin, or bone are a challenge to alleviate especially in rapidly growing children.
Novel technologies may be the answer. This article presents the state-of-art in regen-
erative robotic technologies, which are technologies that assist tissues and organs to
regenerate using sensing and mechanotherapeutical capabilities. It addresses the chal-
lenges in the development of such technologies, among which are autonomy and
fault-tolerance for long-term therapy as well as morphological conformations and
compliance of such devices to adapt to gradual changes of the tissues in vivo. The
potential as medical devices for delivering therapies for tissue growth and as tools
for scientific exploration of regenerative mechanisms is also discussed.
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1 | TISSUE REPAIR
Tissue repair is a complex, long term, and physiologically
demanding process requiring dynamic and optimal therapies
(Eming, Wynn, & Martin, 2017). Patients suffering from
conditions such as long-gap esophageal atresia (LGEA), a
congenital disease in which a section of the esophagus
of 3 cm or more is missing, or short bowel syndrome (SBS),
a devastating condition associated with massive loss or
resection of the small intestine, skin burns, or bone deformi-
ties, are just a few examples of dramatic cases of tissue
reconstruction that challenge patients and surgeons alike.
Currently, the only effective treatment for LGEA consists of
attaching sutures to the end of the esophageal ends, tying
them off at the child's back and tightening them daily for
weeks to encourage the tissue to elongate. During this
treatment, the baby is sedated, and assessed with X-rays
(Foker, Kendall Krosch, Catton, Munro, & Khan, 2009).
In SBS, because the child's remaining bowel length is
insufficient to absorb nutrients and maintain health and
growth, the treatments often target the dilation of the
organ. Yet, the child is dependent on parenteral nutrition
(PN, i.e., intravenous feeding) for months to years (Spencer
et al., 2008) which can lead to morbidities like bloodstream
infections and liver disease. These heroic surgeries per-
formed by a few world experts are sadly primitive and
morbid.
2 | MECHANOTHERAPY
For a long time now, mechanotherapy—a form of physio-
therapy using mechanical equipment to manipulate parts of
the body, along with other exercises, massage, and so
forth—has been recognized as effective for tissue repair,
with treatments spanning months or years. Recent studies
show that tissues grow in response to stimulative strain
(mechanostimulation; Cezar et al., 2016; Folkman &
Moscona, 1978)—this is nowhere seen more readily than
in the growing child, in adults where exercise develops
muscle mass and in pregnant women where skin expands
to accommodate the growing fetus. It has been shown
in vitro that this stimulation applied to cells can change
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their developmental trajectory toward death (necrosis), pro-
liferation or differentiation (Folkman & Moscona, 1978).
Clinically, the principle has been applied to induce bone
growth, for skin grafts (Chua et al., 2016), wound healing
(Huang, Holfeld, Schaden, Orgill, & Ogawa, 2013), growth
of arteries (Kim et al., 2012) and esophagus expansion and
elongation (Foker et al., 2009). However, the treatments
rely on the surgeon's on-site tactile perception or visual
assessment, and empirical training, and thus are inconsis-
tent. When much of the information about diseases is
derived from advanced imaging technology (e.g., X-rays,
ultrasound) the importance of real-time interaction with tis-
sue in understanding immediate and long-term effects of a
therapy seems to be overlooked. With the knowledge of
complex living tissues being at an early stage, inquiries on
the optimal regimens of force application for tissue growth
are needed. Presently, there are no studies about how tissue
regeneration unfolds or is controlled during long-term
mechanostimulation. An in vivo device that enables
informed and automated therapy would thus be extremely
useful.
3 | MEDICAL TECHNOLOGIES FOR
TISSUE REPAIR AND GROWTH
Surgery-assistive robotic devices have been shown to pro-
duce consistent outcomes in tissue repair, albeit their use, as
a tool for surgeons (Shademan et al., 2016), is limited to
manually-operated, daily interventions (Sajadi & Goldman,
2015). Medical implants, such as the pacemaker, usually
operate according to preprogrammed regimens (Copeland
et al., 2004). Tissue engineering, on another front, uses
engineered biomaterials (scaffolds) and growth factors to
encourage host or donor cells to proliferate and grow new
tissue. Despite successes in this field, challenges of cell
death before vascularization of the scaffold, and patient-
specific factors affecting the tissue remodeling potential
remain (Atala, Kasper, & Mikos, 2012).
4 | SOFT ROBOTICS
Soft robots take advantage of both soft material engineering
and robotic control to mimic natural properties, such as
viscoelasticity, smooth motion, deformations, and self-healing
(Rus & Tolley, 2015). Soft robotic growth has also been
investigated by a few studies for even search and rescue
(Hawkes, Blumenschein, Greer, & Okamura, 2017; Rieffel &
Smith, 2014; Sadeghi, Tonazzini, Popova, & Mazzolai,
2014), outside of the medical context. Despite recent devel-
opments in soft medical robots, such as soft neuronal sensors
tested in vivo for days, and heart sleeves assessed in acute
animal studies (Roche et al., 2017; Xu et al., 2014), there is
no robot that has operated in vivo long term. The possibility
to combine chemical, physical and electronic properties in
soft-matter substrates brings unprecedented flexibility in
medical device customization, complexity, and mechanical
compatibility for in vivo environments.
5 | REGENERATIVE ROBOTIC
TECHNOLOGIES
Future tissue therapy should allow sustained, noninvasive,
tissue-responsive repair through autonomous, in-situ,
feedback-controlled robotic implant technologies that regu-
late tissue growth by mechanostimulation (Damian et al.,
2018; Miyashita et al., 2016). The realization of such
devices would enable onboard clinical expertise and deliv-
ery of effective therapy at all times, as well as the acquisi-
tion of in vivo tissue data to research growth mechanisms,
which is impossible in current clinical and research prac-
tice. This technology could customize treatments by exploi-
ting natural growth capabilities of the remaining tissue.
Novel regenerative technologies are emerging and combine
the interdisciplinary knowledge from these fields in order
to provide more reliable, controlled, on-demand tissue ther-
apies for wound healing and tissue growth. Two examples
are given below:
1. Therapeutic hydrogel substrates: Cezar et al. developed
an actuated biologic-free ferrogel able to apply, under a
magnetic field, mechanical compression to damaged
skeletal muscle (Cezar et al., 2016). Their results showed
that this mechanical intervention positively affected the
host inflammatory response, by significantly reducing the
fibrotic capsule around the gel after 2 weeks of implanta-
tion in mice hind limb. Furthermore, the cyclic application
of the mechanical compression led to enhanced muscle
regeneration compared to no-treatment controls, indicat-
ing the potential of regenerative therapies through mecha-
notherapy. The hydrogel substrate allowed a profile of
mechanical compression that produced a better outcome
than the acute compression profile of inflating balloon
cuffs around the mouse limb (Figure 1). In the reported
work the mechanotherapy regimens were predefined, thus
further envisaged improvement could be sensing incorpo-
ration to adapt these regimens to changes of the tissue in
time, such as stiffness.
2. Robotic implants: Damian et al. developed robotic
implants that show capabilities to regulate and enhance
tissue growth through mechanostimulation: by applied
forces to esophageal and bowel tissue in swine animals
(Damian et al., 2014, 2018; Price, Machaidze, Jaksic,
Jennings, & Dupont, 2016; Figure 2). Supported by
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advancement in mechatronic design allowing week-long
robot operation in vivo, an average of 77% of new
esophageal tissue in 9 days was achieved, with 63% of
lengthening due to muscle cell proliferation and 37%
due to collagen formation (fibrosis). These studies have
also revealed a full range of unrecognized challenges
owing to the stiff and fixed implant design operating
long-term in a harsh in vivo environment. Due to the
interaction between the rigid implant and tissue, we
ascertained that the fibrosis level was notable. Also
quick bursts of damaging forces on the tissue at points
of contact with the robot generated by the host tissue's
dynamics were difficult to counteract. Moreover, the
robot was limited in the length of tissue it can grow due
to the fixed mechatronics design.
6 | CHALLENGES AND
OPPORTUNITIES
While the aforementioned technologies, as currently demon-
strated, obviate the need of cell culture and growth factors,
the underlying techniques in tissue engineering may be com-
bined and incorporated to augment outcomes. Advancing
these technologies to the clinic will entail overcoming a con-
glomerate of technological challenges that are derived from
stringent clinical and biological requirements, as outlined in
Table 1.
One requirement to create safe implantable technologies
for patients is to develop those devices that are
biocompatible and mechanically compliant with the tissue. It
has been demonstrated that the latter feature reduces the
inflammatory response of the body (Moshayedi et al., 2014).
Soft sensors, actuators, and robots are able to conform and
comply with the geometry and mechanics of soft tissues,
thus providing a significant potential to meet these require-
ments (Bartlett, Markvicka, & Majidi, 2016; Ilievski,
Mazzeo, Shepherd, Chen, & Whitesides, 2011; Lum et al.,
2016). Importantly, these technologies should also be con-
trollable, enabling the possibility of human intervention in
device operation to override autonomous device operation
whenever needed. While current treatments provide short-
term and periodic interventions, long-term therapies need to
provide the possibility to intervene at any time during the
healing and regenerative process, to maximize the physio-
logical results and minimize the pathological factors. End-
owing these devices with autonomy is key for such
therapies, as such autonomous devices would have to have
access to on-site sensor readings and apply adaptive tissue-
responsive therapies. Autonomy has been demonstrated in
surgical tasks using the Da Vinci robot, which is a robot
comprising of multiple robotic arms designed to perform
surgery inside the body through key-hole incisions
(Shademan et al., 2016). The autonomous surgery with the
Da Vinci robot combined suturing tools and multimodal
imaging, sensing and high-resolution positioning for soft tis-
sue surgery. The results of the autonomous robotic surgery
were superior to manual surgery, laparoscopy, and robot-
assisted surgery for an intestinal anastomosis with ex vivo
porcine tissues and living pigs. The implementation of
autonomous implantable technologies requires accurate
FIGURE 1 Biphasic ferrogels and
pressure cuffs generate cyclic mechanical
compressions. (Top) Schematic of biphasic
ferrogel implant in mouse hind limb
depicting orientation of ferrogel relative to
skin, muscle tissue, and magnet (top left).
Pressure profile of biphasic ferrogel
undergoing repeated magnetic stimulations
(top right). (Bottom) Schematic of pressure
cuff on mouse hind limb depicting
orientation of balloon and polycarbonate
cuff relative to skin and muscle tissue
(bottom left). Pressure profile of balloon
cuff undergoing repeated inflations and
deflations (bottom right; Cezar
et al., 2016)
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knowledge of the tissue for decision-making and for safe,
meaningful and effective therapeutic actions. Additionally, it
is important that autonomy is extended to the resilience of
the device; as an implantable technology residing in inacces-
sible places, the device must be able to operate at all times,
isolating or compensating for potentially occurring internal
device faults (Terryn, Brancart, Lefeber, Van Assche, &
Vanderborght, 2017). Implants for tissue healing and regen-
eration also need to geometrically adapt to the lengthening
tissue as a result of the artificially or biologically induced
tissue growth. The latter one is especially important for pedi-
atric patients. Current approaches consist of materials
that change size due to biodegradability or due to elasticity
(Feins et al., 2017; Perez Guagnelli et al., 2018). Lastly,
it is desirable for such implantable technologies to be
minimally invasive or low-profile, which is critical for
pediatric patients in particular. This requirement has been
addressed using materials that can be deployed from small
to large structures due to swelling or unfolding (Hu, Lum,
Mastrangeli, & Sitti, 2018; Miyashita, Guitron, Li, &
Rus, 2017).
These challenges are interdisciplinary and materialize
into an engineering question of how to create a mechanically
malleable robotic implant that is able to deform and induce
tissue stimulation to effectively reconstruct and restore tissue
performances with minimum human intervention. Apart
from the clinical impact of the regenerative technologies,
they also have the potential to shed light on scientific ques-
tions related to the mechanisms of growth and scar reduction
at both tissue and cellular levels. How to optimize cell
regeneration in a closed loop control? What are viable trac-
tion force regimens that lead to maximization of cell prolif-
eration? What are the in silico and in vitro models that assist
the in vivo tissue growth optimization and reduce animal tri-
als and speed developments to clinical use? How to model
and estimate tissue healing and inflammatory response with
TABLE 1 Clinical and technological challenges in developing regenerative technologies
Clinical challenge Benefit Technological challenge
Safe Patient safety, reduction of inflammation Bio- and mechanically-compliant with
tissues, controllable
Long-term therapy Personalized at-all-times treatment with
monitoring and therapy delivery
throughout the healing process
Programmability, autonomy, adaptive
control, fault-tolerance
Support tissue lengthening Lengthen with the tissue High and sustainable deformation
Minimally or noninvasive Fast recovery time, patient comfort,
reduce inflammation
Miniaturization, biodegradability
FIGURE 2 Robotic implant for tubular tissue growth. (a) For the treatment of long-gap esophageal atresia, the implant applies forces (F) to
disconnected esophageal segments. After inducing sufficient growth, the segments are surgically connected to form a complete esophagus. (b) As a
potential treatment for SBS, the implant applies forces (F) to connected segment of bowel. By inducing sufficient lengthening to support the
absorption of necessary calories and fluids, a dependence on intravenous feeding could be reduced or eliminated. (c) The robot is covered by
biocompatible waterproof skin and is attached to tubular organ by two rings (esophageal segment shown). The upper ring is fixed to the robot body,
whereas lower ring translates along the body (Damian et al., 2018)
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limited sensory information in an in vivo dynamic environ-
ment? Supported by rapid advancements in the fields of tis-
sue engineering, biology and robotics, it is promising that
these interdisciplinary questions will find an answer in the
following years, thus providing the much-needed treatment
to patients young and old.
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